Eckert & Ziegler Strahlen- und Medizintechnik AG buy fabinator
Start price
12.04.19
/
50%
€19.63
Target price
15.05.19
€25.00
Performance (%)
29.94%
End price
15.05.19
€25.50
Summary
This prediction ended on 15.05.19 with a price of €25.50. The prediction had a final performance of 29.94%. fabinator has a follow-up prediction for Eckert & Ziegler Strahlen- und Medizintechnik AG where he still thinks Eckert & Ziegler Strahlen- und Medizintechnik AG is a Buy. fabinator has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Eckert & Ziegler Strahlen- und Medizintechnik AG | -6.205% | -6.205% | 31.724% | -61.626% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
According to fabinator what are the pros and cons of Eckert & Ziegler Strahlen- und Medizintechnik AG for the foreseeable future?
Pros
Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Very capable Management
Very good company culture
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Market Leader or Top 3
Small cyclical dependencies
Very Future proof/growth oriented business model
Cons
High valuation
Low dividend yield expected
Comments by fabinator for this prediction
In the thread Eckert & Ziegler AG diskutieren
Rücksetzer als Chance
Nach dem Rücksetzer auf unter 80€ gibts hier einige Chancen, dass der Kurs wieder steigt.
- Der Finanzmittelbestand zum 31. Dezember 2018 betrug: 54,2 Mio. EUR, keine Schulden
- Prognose für das Geschäftsjahr 2019:
Umsatz ca. 180 Mio. EUR, EBIT ca. 23,5 Mio., Konzerngewinn ca. 18 Mio. EUR (3,50 EUR pro Aktie)
- Ende Mai 2019 Divdende von 1,20 pro Aktie.
(Zielkurs erreicht)
Current prediction by fabinator for Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€48.92
25.04.22
25.04.22
€120.00
03.02.25
03.02.25
-11.55%
18:40
18:40
Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation